Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
基本信息
- 批准号:9144794
- 负责人:
- 金额:$ 163.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-29 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvanced DevelopmentAlgorithmsBiologicalBiological MarkersBlood CellsBone MarrowBostonCategoriesChildChildhoodClinicClinicalClinical DataClinical ResearchCollaborationsCommunitiesCountryCustomDNADNA Sequence AlterationData CollectionDevelopmentDiagnosisDiagnosticDiagnostic testsDiseaseDisease ProgressionDysmyelopoietic SyndromesEssential GenesFailureFutureGeneral PopulationGenesGeneticGenomic approachGenomicsGerm-Line MutationGoalsGrantHealthHematologistHematologyHematopathologyHematopoiesisInborn Genetic DiseasesIncidenceInheritedInvestigationKnowledgeMarrowMedicalMethodologyMethodsMolecularMolecular GeneticsMutationNational Institute of Diabetes and Digestive and Kidney DiseasesPancytopeniaPathogenesisPathologicPathologistPathologyPathway interactionsPatientsPhenotypePopulationProductionRecording of previous eventsResearchResearch PersonnelResource DevelopmentResourcesRoleSamplingSomatic MutationSyndromeTechnologyTestingVariantaccurate diagnosisbaseclinical phenotypecytopeniaevidence baseexomefallsgene discoveryimaging modalityinsightleukemiamembermolecular phenotypemultidisciplinarynext generation sequencingnovelnovel diagnosticsoutcome forecastprogramsrepositoryscreeningtooltranslational studyworking groupyoung adult
项目摘要
DESCRIPTION (provided by applicant): The inherited bone marrow failure and myelodysplastic syndromes (iBMF/MDS) are a heterogeneous group of disorders that are characterized by impaired hematopoiesis and a propensity to progress to leukemia. Despite recent advances in the field, a significant percentage of patients presenting with inherited marrow failure or MDS do not fall into the known diagnostic categories and remain idiopathic. Since many of these genetic syndromes entail specific management and treatment considerations that differ significantly from standard therapies used for acquired marrow failure/MDS, accurate diagnosis is essential. This is a resource development and gene discovery grant investigating iBMF/MDS to characterize their phenotypic spectrum, to develop novel imaging modalities for bone marrow pathology, and to gain insights into the genetic and molecular mechanisms regulating hematopoiesis and marrow failure. We will apply cutting edge genomics approaches to samples from comprehensively phenotyped children and adults to identify new genes responsible for iBMF/MDS. This project will also investigate the clinical and biological consequences of somatically acquired genetic mutations on disease progression and prognosis in iBMF/MDS and determine the similarities or differences in genetic landscapes between inherited versus acquired marrow failure/MDS. We will also interrogate seemingly sporadic marrow failure or MDS presenting in the general population for cryptic presentations of inherited disorders. Resources generated for the broader clinical and scientific communities will include high-throughput multiplexed gene analysis platforms for iBMF/MDS, evidence- based algorithms for the diagnostic workup and management of iBMF/MDS, centralized hematopathology review, and comprehensively clinically annotated biological samples for further investigation. This project should yield new insights into blood cell development and the molecular pathogenesis of marrow failure and MDS; will advance the development of new diagnostic tests, therapies and biomarkers for marrow failure and MDS; will provide clinical resources forthe hematology community; and will provide new tools and methods for future studies ofthe molecular pathways regulating hematopoiesis.
描述(由申请人提供):遗传的骨髓衰竭和骨髓增生综合征(IBMF/MDS)是一组异质性疾病,其特征是造血受损,并且倾向于促进白血病。尽管该领域最近取得了进步,但在遗传骨髓衰竭或MD的患者中,很大一部分并不属于已知的诊断类别,并且仍然保持特发性。由于这些遗传综合症中的许多都需要特定的管理和治疗考虑因素,这些因素与用于获得的骨髓衰竭/MD的标准疗法显着不同,因此准确的诊断至关重要。这是研究IBMF/MD的资源开发和基因发现赠款,以表征其表型谱,开发出新的成像骨髓病理学的成像方式,并深入了解调节造血和骨髓衰竭的遗传和分子机制。我们将对来自全面表型儿童和成人的样本应用最前沿的基因组学方法,以鉴定负责IBMF/MD的新基因。该项目还将调查IBMF/MDS中遗传突变对疾病进展和预后的临床和生物学后果,并确定遗传景观与获得的骨髓衰竭/MD之间的遗传景观的相似性或差异。我们还将询问看似零星的骨髓衰竭或在普通人群中呈现的MD,以表现出遗传性疾病的神秘表现。为更广泛的临床和科学社区生成的资源将包括用于IBMF/MD的高通量多路复用基因分析平台,基于证据的算法,用于IBMF/MDS的诊断工作和管理,集中的血液病理学评论,以及全面的临床临床生物学样本。该项目应为血细胞发育以及骨髓衰竭和MD的分子发病机理提供新的见解。将推动开发新的诊断测试,疗法和生物标志物,用于骨髓衰竭和MDS;将为血液学社区提供临床资源;并将为调节造血的分子途径提供新的工具和方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janis L Abkowitz其他文献
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
剂量调整后的 EPOCH 加 Inotuzumab Ozogamicin 用于治疗复发或难治性 B 细胞 ALL 成人患者:1 期剂量递增试验。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:28.4
- 作者:
N. E. Kopmar;Kim Quach;T. Gooley;C. Martino;S. Cherian;M. Percival;A. Halpern;C. Ghiuzeli;V. Oehler;Janis L Abkowitz;Roland B Walter;R. Cassaday - 通讯作者:
R. Cassaday
Structural and mechanistic insights into human choline and ethanolamine transport
对人类胆碱和乙醇胺运输的结构和机制的见解
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Keiken Ri;Tsai;Ainara Claveras Cabezudo;Wiebke Jösting;Zhang Yu;Andre Bazzone;Nancy C P Leong;Sonja Welsch;R. Doty;Gonca Gursu;Tiffany Jia Ying Lim;Sarah Luise Schmidt;Janis L Abkowitz;Gerhard Hummer;Di Wu;Long N. Nguyen;S. Safarian - 通讯作者:
S. Safarian
Janis L Abkowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janis L Abkowitz', 18)}}的其他基金
Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
- 批准号:
10773217 - 财政年份:2023
- 资助金额:
$ 163.61万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
9350172 - 财政年份:2013
- 资助金额:
$ 163.61万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
8734906 - 财政年份:2013
- 资助金额:
$ 163.61万 - 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
- 批准号:
8583491 - 财政年份:2013
- 资助金额:
$ 163.61万 - 项目类别:
Clinical and Molecular Characterization of Familial Marrow Failure Syndrome
家族性骨髓衰竭综合征的临床和分子特征
- 批准号:
8214798 - 财政年份:2012
- 资助金额:
$ 163.61万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8257066 - 财政年份:2011
- 资助金额:
$ 163.61万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8668043 - 财政年份:2011
- 资助金额:
$ 163.61万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8004431 - 财政年份:2011
- 资助金额:
$ 163.61万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8541530 - 财政年份:2011
- 资助金额:
$ 163.61万 - 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
- 批准号:
8454539 - 财政年份:2011
- 资助金额:
$ 163.61万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating Disparities in End-of-Life Care in Undocumented Hispanic Immigrants
调查无证西班牙裔移民临终关怀方面的差异
- 批准号:
10593462 - 财政年份:2023
- 资助金额:
$ 163.61万 - 项目类别:
Impact of Autonomic Dysfunction on Multi-Organ Dysfunction following Severe TBI: The AUTO-BOOST Study
严重 TBI 后自主神经功能障碍对多器官功能障碍的影响:AUTO-BOOST 研究
- 批准号:
10607731 - 财政年份:2023
- 资助金额:
$ 163.61万 - 项目类别:
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 163.61万 - 项目类别: